These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15388423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents.
    Qi X, Xiong S, Yang H, Miller M, Delaney WE.
    Antivir Ther; 2007; 12(3):355-62. PubMed ID: 17591025
    [Abstract] [Full Text] [Related]

  • 5. Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir.
    Brunelle MN, Jacquard AC, Pichoud C, Durantel D, Carrouée-Durantel S, Villeneuve JP, Trépo C, Zoulim F.
    Hepatology; 2005 Jun; 41(6):1391-8. PubMed ID: 15915463
    [Abstract] [Full Text] [Related]

  • 6. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O, Benhamou Y, Cahour A, Katlama C, Poynard T, Thibault V.
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [Abstract] [Full Text] [Related]

  • 7. Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance.
    Yang HJ, Lee JH, Kim YJ, Yoon JH, Lee HS.
    J Med Virol; 2012 Mar; 84(3):424-30. PubMed ID: 22246827
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the in vitro anti-HBV activity of clevudine in combination with other nucleoside/nucleotide inhibitors.
    Niu C, Bao H, Tolstykh T, Micolochick Steuer HM, Murakami E, Korba B, Furman PA.
    Antivir Ther; 2010 Mar; 15(3):401-12. PubMed ID: 20516559
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy.
    Ijaz S, Arnold C, Dervisevic S, Mechurova J, Tatman N, Tedder RS, Naoumov NV.
    J Med Virol; 2008 Jul; 80(7):1160-70. PubMed ID: 18461609
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir.
    Zaaijer HL, Takkenberg RB, Weegink CJ, Rebers SP, Menting S, Reesink HW, Schinkel J, Molenkamp R.
    J Med Virol; 2009 Mar; 81(3):413-6. PubMed ID: 19152408
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Novel acyclic nucleoside phosphonate analogues with potent anti-hepatitis B virus activities.
    Ying C, Holy A, Hocková D, Havlas Z, De Clercq E, Neyts J.
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1177-80. PubMed ID: 15728921
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.
    Wiegand J, Tischendorf JJ, Nashan B, Klempnauer J, Flemming P, Niemann P, Rohde P, Manns MP, Trautwein C, Tillmann HL.
    Z Gastroenterol; 2004 Jan; 42(1):15-8. PubMed ID: 14997399
    [Abstract] [Full Text] [Related]

  • 20. Mutations associated with the therapeutic efficacy of adefovir dipivoxil added to lamivudine in patients resistant to lamivudine with type B chronic hepatitis.
    Ohkawa K, Takehara T, Kato M, Kanada A, Deguchi M, Kagita M, Hikita H, Sasakawa A, Kohga K, Uemura A, Sakamori R, Yamaguchi S, Miyagi T, Ishida H, Tatsumi T, Hayashi N.
    J Med Virol; 2009 May; 81(5):798-806. PubMed ID: 19319954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.